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Pericardium Plug in the Repair of the Corneoscleral 
Fistula After Ahmed Glaucoma Valve Explantation
Chungkwon Yoo, MD, Sung Wook Kwon, MD, Yong Yeon Kim, MD, PhD
Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea
We report four cases in which a pericardium (Tutoplast
®) plug was used to repair a corneoscleral fistula after 
Ahmed Glaucoma Valve (AGV) explantation. In four cases in which the AGV tube had  been exposed, AGV 
explantation was performed using a pericardium (Tutoplast
®) plug to seal the defect previously occupied by 
the tube. After debridement of the fistula, a piece of processed pericardium (Tutoplast
®), measured 1 mm 
in width, was plugged into the fistula and secured with two interrupted 10-0 nylon sutures. To control 
intraocular pressure, a new AGV was implanted elsewhere in case 1, phaco-trabeculectomy was performed 
concurrently in case 2, cyclophotocoagulation was performed postoperatively in case 3 and 
anti-glaucomatous medication was added in case 4. No complication related to the fistula developed at the 
latest follow-up (range: 12~26 months). The pericardium (Tutoplast
®) plug seems to be an effective method 
in the repair of corneoscleral fistulas resulting from explantation of glaucoma drainage implants.
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Glaucoma drainage implants (GDIs) have been an effective 
therapeutic option in the management of refractory glaucoma. 
The complications associated with GDIs, however, include 
hypotony, choroidal effusion, corneal decompensation, 
cataract, endophthalmitis, diplopia, and migration of the 
implant.
1,2 Erosion of the silicone tube through the overlying 
conjunctiva has also been recognized, and various methods 
such as a conjunctival advancement, a conjunctival patch 
graft, an amniotic membrane patch graft or an interpolated 
conjunctival pedicle flap have been described to cover the 
exposed tube.
3-6 However, if these methods turn out 
unsuccessful or can not be utilized and the patient has 
implant-related intractable pain, inflammation, or 
endophthalmitis, the GDIs may have to be explanted from the 
eye.
Explantation of a GDIs necessitates the repair of the fistula 
in the cornea and the sclera, which was previously occupied 
by the silicone tube. The corneoscleral fistula, if repaired 
with sutures alone, may lead to significant astigmatism or 
wound dehiscence. Sibayan et al.
7 first reported the successful 
use of a processed pericardium to manage the corneoscleral 
fistula after explantation of GDIs. We describe four cases in 
which a pericardium (Tutoplast
®, Innovative Ophthalmic 
Products, Costa Mesa, California, USA) plug was used to 
repair a corneoscleral fistula after Ahmed glaucoma valve 
(AGV New World Medical, Inc, Rancho Cucamonga, 
California, USA) explantation, and the postoperative 
outcomes from these cases which have been followed up for 
12 months or longer.
Case Report
Case 1: A 49-year-old man with neovascular glaucoma 
(NVG) in the right eye (RE), who had undergone 
phacoemulsification, posterior chamber lens (PCL) 
implantation, and AGV implantation, was referred to us. His 
intraocular pressure (IOP) (RE) was 40 mmHg despite 
medical therapy including dorzolamide 2% / timolol maleate 
0.5% fixed combination (Cosopt
®, Merck & Co., Inc., Blue 
Bell, PA, USA), latanoprost 0.005% (Xalatan
®, Pfizer, Inc., 
New York, NY, USA), and brimonidine purite 0.15% 
(Alphagan P
® 0.15%; Allergan, Inc., Irvine, CA, USA). The 
AGV tube as well as its body was found exposed with 
complete melting of the patch graft and conjunctiva. The 
body of the valve was located close to the limbus (4 mm 
posterior to the limbus): in addition, this diabetic patient 
suffered from severe ocular pain (Fig. 1). Surgery was 
planned to remove the preexisting AGV and insert a new C Yoo, et al. PERICARDIUM PLUG IN CORNEOSCLERAL FISTULA REPAIR 
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Table 1. Summary of the features of 4 cases in whom a pericardial plug was used to repair the corneoscleral 




Previous OP Combined OP
Postop
Additional measures
Va IOP (mmHg) Va IOP (mmHg)
1 (OD) M/49 NVG 0.15 40 PE
AGV
2nd AGV 0.2 18 none
2 (OS) M/61 NVG FC 9 AGV PE
Trab
HM 13 none
3 (OS) M/56 NVG HM 15 PPV
PE
AGV
None HM 14 CPC
4 (OS) M/17 CG 0.04 6 Trabeculotomy
Trab
2 AGVs
None 0.02 17 Cosopt &
Alphagan-P
added
Dx=diagnosis; Preop=preoperative; Postop=at the last postoperative visit; Va=visual acuity; IOP=intraocular pressure; OP= 
operation; NVG=neovascular glaucoma; CG=congenital glaucoma; FC=finger count; HM=hand motion; PE=phacoemulsification 
and intraocular lens implantation; AGV=Ahmed glaucoma valve implantation; PPV=pars plana vitrectomy; Trab=trabeculectomy; 
CPC=cyclophotocoagulation.
Fig. 1. Exposure of the tube and the body of the preexisting 
Ahmed Glaucoma Valve is shown with complete melting of the 
pericardium patch graft. The body of the AGV was located 4 
mm posteriorly to the limbus. 
Fig. 2. Schematic illustration of the pericardium plug (black 
arrow) which is secured with 10-0 Nylon sutures (white arrow) 
to seal the defect previously occupied by the silicone tube of 
Ahmed glaucoma valve. 
AGV in another quadrant because we believed that the 
preexisting AGV was non-functioning and pain-evoking. In 
addition, we believed that insertion of a new AGV into the 
same place might predispose the patient to a recurrence of 
exposure.
Under peribulbar anesthesia, a conjunctival peritomy was 
performed alongside the area of transconjunctival tube 
erosion, and the tube of the AGV was removed from the 
anterior chamber. To seal the space previously occupied by 
the tube, the fistula was debrided with a No. 11 Bard-Parker 
blade and a Weckcel
® sponge. A piece of processed 
pericardium (Tutoplast
®), measured 1 mm in width, was then 
plugged into the fistula. The pericardium was trimmed flush 
to the external opening and secured with two interrupted 10-0 
nylon sutures (Fig. 2). Next, the plate of the AGV was 
explanted from the underlying sclera. The conjunctiva was 
drawn back in place and sutured. For implantation of a new 
AGV, a fornix-based incision was made through the 
conjunctiva and the Tennon’s capsule at the superonasal 
quadrant. A pocket was created between the superior rectus 
and the medial rectus muscles by blunt dissection of the 
Tennon’s capsule from the episclera. A new valve body was 
inserted into the pocket with its leading edges 8 mm posterior 
to the limbus. The tube of the valve was trimmed to permit 
a 2 mm insertion into the anterior chamber. A paracentesis 
was performed, and the anterior chamber was entered at the 
limbus with a sharp 23 G needle, parallel to the iris. The 
drainage tube was inserted through the needle track. The tube 
was secured to the sclera with two 10-0 Nylon sutures, and 
covered with pericardium (Tutoplast
®). The conjunctiva and 
the Tennon’s capsule were closed with 10-0 Nylon sutures.
The IOP ranged from 8 to 20 mmHg during the 
postoperative one month. At postoperative 14 months, IOP 
was 18 mm Hg and no fistula-related complication such as 
wound dehiscence or pericardium melting was noted.Korean J Ophthalmol Vol.22, No.4, 2008
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Fig. 3. (A) Slit-lamp photo shows the tube exposed externally through overlying conjunctival erosion. (B) Slit-lamp photo shows the 
pericardium plugged (black arrow) in the corneal fistula at 12 months after AGV explantation. 
Fig. 4. (A) Slit-lamp photo shows the tube exposed externally through the overlying conjunctival erosion. Hypopyon is also noted. (B) 
Slit-lamp photo shows the pericardium plugged (black arrow) in the corneal fistula at 7 months after AGV explantation.
Case 2: A 61-year-old man with diabetes mellitus, 
hypertension and NVG (LE) had undergone AGV 
implantation (LE) 19 months prior to its explantation. At 4 
months postoperative, exposure of the AGV tube was noted. 
Except for mild hyperemia around the exposed tube, no 
significant inflammatory sign was noted in the anterior 
chamber or around the tube. IOP stayed under 20 mm Hg. 
However, the cataract of his left eye worsened enough to 
preclude a view of the fundus.  Nineteen months after the 
AGV implantation, phacoemulsification, posterior chamber 
lens (PCL) implantation, AGV explantation and 
trabeculectomy with an intraoperative application of 
Mitomycin-C (0.2 mg/ml for 2 minutes) were performed 
concurrently on his left eye. The AGV was explanted by the 
method described previously. The IOP ranged from 9 to 23 
mmHg during the early postoperative 3 months. At the latest 
follow-up at postoperative 23 months, the IOP was 13 mm 
Hg and no fistula-related complication was found (Fig. 3).
Case 3: A 56-year-old diabetic man who had undergone 
pars plana vitrectomy, phacoemulsification, PCL implantation 
and AGV implantation (LE) complained of ocular pain at 
postoperative 2 years. Hypopyon and exposure of AGV tube 
were noted. The patient was immediately treated with a 
topical fluoroquinolone (ciprofloxacin) hourly for presumed 
endophthalmitis. The next day the AGV was explanted using 
the aforementioned method. With topical antibiotics, the 
anterior chamber reaction resolved completely. No cultures 
yielded any organisms. However, at the postoperative day 
one, the IOP went up to the 40s. Diode laser transscleral 
cyclophotocoagulation was performed to control IOP. At 
postoperative 12 months, and the IOP was in the late 10s 
without any complications (Fig. 4).
Case 4: A 17-year-old man, who had undergone 
trabeculotomy, trabeculectomy and AGV implantation (LE) 
for congenital glaucoma, underwent a second AGV 
implantation (LE). Two months postoperatively, the tube of 
the second AGV was noted exposed. Explantation of the 
second AGV was performed using the pericardial plug in the 
aforementioned manner. The next day after the surgery, the 




®) were added postoperatively. 
During the postoperative 26 months, the anterior segment 
remained stable with IOP under control.
Discussion
Transconjunctival tube erosion is an infrequent but 
well-known complication of GDIs surgery. It is estimated that 
2~7% of patients undergoing GDIs procedure develop 
melting of the overlying scleral or pericardial patch with 
erosion of the tube through the conjunctiva.
8-13 Possible 
causes of conjunctival erosion include mechanical abrasion of 
the conjunctiva by the lid, excessive conjunctival tension over 
the tube, tube malposition, or lack of a smooth and tapered 
surface between the patch graft and the host along with poor 
ocular lubrication.
10 Patch grafts like sclera, fascia lata, or 
dura mater may thin or disappear after implantation, 
secondary to ocular inflammation or a host-graft reaction.
10 
Pericardial patch grafts, which are supposed to be cell-free 
and without any antigenic stimuli, have also been reported to 
melt.
4,10
Management of the exposed tube includes conjunctival 
autograft, scleral patch graft, amniotic membrane patch graft, 
and removal of the tube.
3-6 If the tube exposure is 
accompanied by the infectious inflammatory signs which do 
not respond to antibiotics, the tube and the valve plate should 
be removed to help stop the propagation of the infectious 
process and prevent the subsequent development of 
endophthalmitis. Although the explantation of a GDIs is a 
simple procedure, it leaves an opening in the cornea and 
sclera that may not self-seal. If the GDIs has been implanted 
for a long period of time, it can be difficult to close the 
fistula which has been occupied by the tube.
7 Mere direct 
sutures may close the defect. However, this would require a 
great amount of tissue tension and thus induce a significant 
amount of astigmatism which may be bothersome to an eye 
with good visual potential. Even if the fistula is sealed tight 
initially, there is still a chance that the fistula may recur later 
and lead to aqueous leakage if the suture is not strong enough 
to withstand the tissue tension. Therefore, tissue replacement 
may be an effective method to seal off the fistula, because 
it induces much less astigmatism postoperatively. Since the 
pericardium is highly biocompatible and provides an 
immediate and permanent seal, we used a pericardial plug to 
replace the corneoscleral fistula when explanting the AGV in 
all four of our cases.
Since Sibayan et al.
7 first description of this surgical 
technique, there has been no published report of utilization 
of this method and its postoperative results. In Sibayan et al. 
study, they presented only the postoperative fourth week 
outcome of a single case. Our present study demonstrates the 
postoperative results of four cases that were followed up for 
a longer period. No fistula-related complication such as 
wound inflammation, leakage, or pericardium melting has 
been noted in any of our cases till the latest postoperative 
follow-up ranging from 12 to 26 months. Although the 
number of cases in our study is fairly small and the follow-up 
period is still short to verify the efficacy and stability of the 
method, the preliminary data of our cases may give support 
to the use of pericardium plug in such aforementioned 
conditions.
In conclusion, the pericardium plug seems to be an 
effective method in the repair of corneoscleral fistulas 
resulting from explantation of glaucoma valve implants. 
However, a prospective study of a larger number of cases 
with a long-term follow-up will be needed to ensure the 
stability of this method.
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